ACADIAN ASSET MANAGEMENT LLC - CIDARA THERAPEUTICS INC ownership

CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 67 filers reported holding CIDARA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of CIDARA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$1,194
+25.9%
941,574
-25.1%
0.01%0.0%
Q4 2022$948
-99.9%
1,256,602
+3.5%
0.01%
+25.0%
Q3 2022$760,000
+39.4%
1,213,531
+8.9%
0.00%
+33.3%
Q2 2022$545,000
-40.4%
1,114,837
+1.4%
0.00%
-25.0%
Q1 2022$914,000
-19.0%
1,099,299
+23.6%
0.00%0.0%
Q4 2021$1,128,000
-14.1%
889,469
+51.6%
0.00%
-20.0%
Q3 2021$1,313,000
+52.9%
586,848
+38.1%
0.01%
+66.7%
Q2 2021$859,000
+11.6%
424,974
+46.7%
0.00%0.0%
Q1 2021$770,000
+15.3%
289,654
-13.2%
0.00%0.0%
Q4 2020$668,000
-29.5%
333,641
+0.3%
0.00%
-25.0%
Q3 2020$948,000
-3.4%
332,568
+25.1%
0.00%0.0%
Q2 2020$981,000
+112.3%
265,920
+42.8%
0.00%
+33.3%
Q1 2020$462,000
+62.7%
186,215
+151.6%
0.00%
+200.0%
Q4 2019$284,000
+155.9%
74,013
+12.3%
0.00%0.0%
Q2 2019$111,000
-43.9%
65,884
-11.8%
0.00%0.0%
Q1 2019$198,000
+3.7%
74,708
-8.1%
0.00%0.0%
Q4 2018$191,000
-46.6%
81,3280.0%0.00%0.0%
Q3 2018$358,000
-20.4%
81,328
-6.0%
0.00%
-50.0%
Q2 2018$450,000
+177.8%
86,515
+113.6%
0.00%
+100.0%
Q1 2018$162,00040,4960.00%
Other shareholders
CIDARA THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
INTERWEST VENTURE MANAGEMENT CO 1,356,813$3,189,0004.48%
Omega Fund Management, LLC 1,508,794$3,546,0002.63%
ALETHEA CAPITAL MANAGEMENT, LLC 482,357$1,134,0001.65%
Opaleye Management Inc. 1,200,000$2,820,0001.05%
BVF INC/IL 2,904,684$6,826,0000.89%
FRAZIER MANAGEMENT LLC 1,312,258$3,084,0000.80%
Monashee Investment Management LLC 480,851$1,130,0000.76%
Aisling Capital LLC 1,021,148$2,400,0000.68%
Trellus Management Company, LLC 94,143$221,0000.50%
Prosight Management, LP 245,764$578,0000.30%
View complete list of CIDARA THERAPEUTICS INC shareholders